A ranar 5 ga Janairu, 2021, Shangke Biopharmaceutical (Shanghai) Co., Ltd. ta sami kyautar "(S)-1-tert-butoxycarbonyl-3-hydroxypiperidine" Aikin Canjin Fasaha na Babban Fasaha na Shanghai.
A matsayinta na babbar kamfani a fannin fasaha ta ƙasa, Suntech Biotech koyaushe tana ɗaukar fasahar kere-kere don jagorantar ci gaban masana'antar sinadarai da magunguna, kuma tana kawo wa ɗan adam lafiya da walwala a matsayin manufarta. Don faɗaɗa kasuwancin ta hanyoyi da yawa, yin aiki tare da makarantu da kamfanoni sanannu a cikin gida da waje, ci gaba da haɓaka damar haɓaka ta, inganta tsarin cikin gida na kamfanin, da kuma zama mafi kyau da ƙarfi.
Sunan aikin: (S)-1-tert-Butoxycarbonyl-3-hydroxypiperidine
Lambar Kaya: 202010694
Matakin abu: B
Ko akwai nasarori a fannin fasaha mai zurfi tare da haƙƙin mallakar fasaha mai zaman kansa: Eh
Amfani: (S)-1-tert-butoxycarbonyl-3-hydroxypiperidine (CAS: 143900-44-1) muhimmin maganin chiral ne don haɗa ibrutinib APIs. Ibrutinib sabon magani ne na maganin ciwon daji wanda ke nufin cutar B-cell wanda Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da shi a ƙarƙashin amincewar gaggawa a ranar 13 ga Nuwamba, 2013 don maganin lymphoma.
Ma'anar canjin nasarorin fasaha mai zurfi
Sauyin nasarorin fasaha mai zurfi yana nufin tsarin da kamfanoni ke yin samarwa da aiki a fannin fasaha mai zurfi. Gwamnati tana goyon bayan kamfanoni su aiwatar da sauyin nasarorin kimiyya da fasaha ta hanyar bincike da ci gaba mai zaman kansa, bayar da lasisi, karɓar hannun jari a farashi mai rahusa, da kuma yin aiki tare da masana'antu, jami'o'i da cibiyoyin bincike. Ga ayyukan canji na fasaha mai zurfi da kamfanin ya sake dubawa kuma ya bayar da rahoto, bisa ga kammala cikakkun alamun tattalin arziki da halayen haƙƙin mallakar fasaha na aikin, matakin kirkire-kirkire, da sauransu, jarin bincikensa da haɓaka shi yana da alaƙa da haƙƙin mallakar fasaha da ya shafi aikin, takaddun shaidar mallakar fasaha na ƙirƙira, ko waɗanda ke shiga matakin jarrabawa mai mahimmanci. Takardar shaidar girmamawa da aka bayar ga kamfanin bayan cikakken bita da bincike mai zurfi a kasuwa, kamar kayan shaidar aikace-aikacen haƙƙin mallaka na ƙirƙira, takardar shaidar haƙƙin mallaka na samfurin amfani, takardar shaidar rijistar haƙƙin mallaka na software, takardar shaidar rajistar ƙirar tsarin kewaye da aka haɗa, da sauransu.
Bayanin Kamfani
An kafa Shangke Biomedical (Shanghai) Co., Ltd. a shekarar 2008 kuma tana cikin International Medical Park, yankin kudu na Zhangjiang Hi-Tech Park, Pudong, Shanghai. Ita ce reshen kamfanin Zhejiang Shangke Biomedical Co., Ltd. mallakarta gaba ɗaya. Shangke Bio ta himmatu wajen bincike da haɓaka mafi kyawun fannin magunguna masu kore, tana jagorantar ci gaban masana'antar magunguna masu sinadarai tare da fasahar kere-kere, kuma tana ba da kayayyaki masu ƙirƙira da ayyuka masu inganci ga masana'antar magunguna. Ita ce babbar masana'anta a Shanghai kuma ita ce babbar masana'anta ta Shanghai mai suna "Kwarewa, Mai Kyau, Na Musamman da Sabo".
Babban kasuwancin Suntech ya haɗa da: haɓakawa da amfani da enzymes na halitta, haɓakawa da samar da tsaka-tsakin magunguna, APIs da sinadarai masu aiki. Manyan samfuran kamfanin sune samfuran coenzyme, gami da NMN, NAD, NADP, NADH, NADPH, enzymes na halitta, kayan masarufi na magunguna da tsaka-tsakin magunguna. Abokan ciniki da abokan hulɗar kamfanin suna ko'ina cikin duniya, kuma sun ƙulla alaƙar haɗin gwiwa da kamfanonin magunguna da yawa a Arewacin Amurka, Turai, Indiya da China.
Lokacin Saƙo: Janairu-15-2021